Calcium Channel Blockers and Esophageal Sclerosis: Should We Expect Exacerbation of Interstitial Lung Disease

Calcium Channel Blockers and Esophageal Sclerosis: Should We Expect Exacerbation of Interstitial Lung Disease

Esophageal sclerosis is the most common visceral manifestation of systemic sclerosis, resulting in impaired esophageal clearance and retention of ingested food; in addition, co-existence of lung fibrosis with esophageal scleroderma is not uncommon. Both the progression of generalized connective tiss...

Full description

Bibliographic Details
Main Authors: Charalampos Seretis, Fotios Seretis, George Gemenetzis, Nikolaos Liakos, Apostolos Pappas, Stavros Gourgiotis, Emmanuel Lagoudianakis, Dimitrios Keramidaris, Nikolaos Salemis
Format: Article
Language:English
Published: Karger Publishers 2012-01-01
Series:Case Reports in Gastroenterology
Subjects:
Hypoxia
Sclerosis
Aspiration
Esophagus
Raynaud syndrome
Nifedipine
Emergency
Online Access:http://www.karger.com/Article/FullText/336584

Similar Items

Similar Items